Treatment of Femoropopliteal Artery In-stent Restenosis

Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Wonho, Choi, Donghoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861311/
https://www.ncbi.nlm.nih.gov/pubmed/29557105
http://dx.doi.org/10.4070/kcj.2018.0074
_version_ 1783308070701498368
author Kim, Wonho
Choi, Donghoon
author_facet Kim, Wonho
Choi, Donghoon
author_sort Kim, Wonho
collection PubMed
description Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus exists regarding the best treatment algorithm. In this article, we review the limitations of the currently used devices for the endovascular treatment of FP artery-ISR and discuss which strategies are the most effective and safe.
format Online
Article
Text
id pubmed-5861311
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-58613112018-03-21 Treatment of Femoropopliteal Artery In-stent Restenosis Kim, Wonho Choi, Donghoon Korean Circ J Review Article Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus exists regarding the best treatment algorithm. In this article, we review the limitations of the currently used devices for the endovascular treatment of FP artery-ISR and discuss which strategies are the most effective and safe. The Korean Society of Cardiology 2018-03-09 /pmc/articles/PMC5861311/ /pubmed/29557105 http://dx.doi.org/10.4070/kcj.2018.0074 Text en Copyright © 2018. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kim, Wonho
Choi, Donghoon
Treatment of Femoropopliteal Artery In-stent Restenosis
title Treatment of Femoropopliteal Artery In-stent Restenosis
title_full Treatment of Femoropopliteal Artery In-stent Restenosis
title_fullStr Treatment of Femoropopliteal Artery In-stent Restenosis
title_full_unstemmed Treatment of Femoropopliteal Artery In-stent Restenosis
title_short Treatment of Femoropopliteal Artery In-stent Restenosis
title_sort treatment of femoropopliteal artery in-stent restenosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861311/
https://www.ncbi.nlm.nih.gov/pubmed/29557105
http://dx.doi.org/10.4070/kcj.2018.0074
work_keys_str_mv AT kimwonho treatmentoffemoropoplitealarteryinstentrestenosis
AT choidonghoon treatmentoffemoropoplitealarteryinstentrestenosis

Ejemplares similares